← Leaderboards
Jeremy David Keenan
University Of California, San Francisco
$19,787,326
Attributed
$21,019,786
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,624,094 · 11
CDC$1,395,692 · 1
By mechanism
UG1$13,286,042 · 4
U10$2,650,100 · 1
U01$1,395,692 · 1
R21$1,286,150 · 3
K23$982,094 · 1
R33$981,211 · 1
Top collaborators
- Andres G Lescano6 shared
- Yvonne Ou2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Jennifer Rose-Nussbaumer$10,499,043
- Catherine Elizabeth Oldenburg$6,320,431
- Thuy A Doan$5,287,003
- Marlys S Fassett$1,048,990
Others in their field
Top investigators on “Blindness”
- Randall J Bateman · Washington University$137,189,188
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$96,562,493
Research focus
BlindnessCommunitiesWorld Health OrganizationProgramsRandomizedTrachomaMonitorResourcesInfectionAffectChildVisual AcuityPreventEvidence BaseDiagnosisPublic HealthPhotographyCost EffectiveAzithromycinChlamydiaAntibiotic TherapyEthiopiaResearch PersonnelAntibiotics
Grant awards (42)
Parasitic Ulcer Treatment Trial$1,187,979
UG1 · FY2025 · EY · contact PI
Village-Integrated Eye Worker Trial II (VIEW II) Extension$785,986
UG1 · FY2025 · EY · contact PI
DP24-081 Novel telehealth technologies to detect and manage glaucoma and vision-threatening eye diseases in high-risk populations$700,000
U01 · FY2025 · DP · contact PI
Integrating smartphone photography for trachoma, smartphone visual acuity assessment, and mobile autorefraction to enhance community-based public health monitoring$296,259
R33 · FY2025 · EY · contact PI
Exploring the role of metagenomic deep sequencing for trachoma$205,000
R21 · FY2025 · EY · contact PI
Village-Integrated Eye Worker Trial II (VIEW II) Extension$1,448,874
UG1 · FY2024 · EY · contact PI
Parasitic Ulcer Treatment Trial$1,179,904
UG1 · FY2024 · EY · contact PI
DP24-081 Novel telehealth technologies to detect and manage glaucoma and vision-threatening eye diseases in high-risk populations$695,692
U01 · FY2024 · DP · contact PI
Developing methods for the use of conjunctival photographs for trachoma monitoring$450,874
R21 · FY2024 · EY · contact PI
Integrating smartphone photography for trachoma, smartphone visual acuity assessment, and mobile autorefraction to enhance community-based public health monitoring$281,550
R33 · FY2024 · EY · contact PI
Exploring the role of metagenomic deep sequencing for trachoma$246,000
R21 · FY2024 · EY · contact PI
Parasitic Ulcer Treatment Trial - Diversity Supplement$138,099
UG1 · FY2024 · EY · contact PI
Integrating smartphone photography for trachoma, smartphone visual acuity assessment, and mobile autorefraction to enhance community-based public health monitoring$79,960
R33 · FY2024 · EY · contact PI
Integrating smartphone photography for trachoma, smartphone visual acuity assessment, and mobile autorefraction to enhance community-based public health monitoring - Diversity Supplement$26,517
R33 · FY2024 · EY · contact PI
Parasitic Ulcer Treatment Trial$1,562,129
UG1 · FY2023 · EY · contact PI
Sanitation, Water, and Instruction in face-washing for trachoma II (SWIFT II)$974,886
UG1 · FY2023 · EY · contact PI
Integrating smartphone photography for trachoma, smartphone visual acuity assessment, and mobile autorefraction to enhance community-based public health monitoring$296,925
R33 · FY2023 · EY · contact PI
Admin Supplement: Village-Integrated Eye Worker Trial II (VIEW II)$86,500
UG1 · FY2023 · EY · contact PI
Sanitation, Water, and Instruction in face-washing for trachoma II (SWIFT II)$797,567
UG1 · FY2022 · EY · contact PI
Village-Integrated Eye Worker trial II (VIEW II)$678,295
UG1 · FY2022 · EY · contact PI
Integrating smartphone photography for trachoma, smartphone visual acuity assessment, and mobile autorefraction to enhance community-based public health monitoring$182,401
R21 · FY2022 · EY · contact PI
Sanitation, Water, and Instruction in face-washing for trachoma II (SWIFT II)$747,428
UG1 · FY2021 · EY · contact PI
Village-Integrated Eye Worker trial II (VIEW II)$422,116
UG1 · FY2021 · EY · contact PI
Integrating smartphone photography for trachoma, smartphone visual acuity assessment, and mobile autorefraction to enhance community-based public health monitoring$201,875
R21 · FY2021 · EY · contact PI
Diversity Supplement: Village Integrated Eye Worker Trial II Validation Study$93,282
UG1 · FY2021 · EY · contact PI
Sanitation, Water, and Instruction in face-washing for trachoma II (SWIFT II)$749,549
UG1 · FY2020 · EY · contact PI
Village-Integrated Eye Worker trial II (VIEW II)$410,811
UG1 · FY2020 · EY · contact PI
Sanitation, Water, and Instruction in face-washing for trachoma II (SWIFT II)$857,320
UG1 · FY2019 · EY · contact PI
Village-Integrated Eye Worker trial II (VIEW II)$444,928
UG1 · FY2019 · EY · contact PI
Village-Integrated Eye Worker trial II (VIEW II)$720,389
UG1 · FY2018 · EY · contact PI
Sanitation, Water, and Instruction in Face-washing for Trachoma$584,680
U10 · FY2018 · EY · contact PI
Sanitation, Water, and Instruction in Face-washing for Trachoma$465,880
U10 · FY2017 · EY · contact PI
Sanitation, Water, and Instruction in Face-washing for Trachoma$465,880
U10 · FY2016 · EY · contact PI
Sanitation, Water, and Instruction in Face-washing for Trachoma$469,720
U10 · FY2015 · EY · contact PI
Sanitation, Water, and Instruction in Face-washing for Trachoma$663,940
U10 · FY2014 · EY · contact PI
Planning Grant for Parasitic Ulcer Treatment Trial$219,793
R34 · FY2013 · EY · contact PI
Planning Grant for Parasitic Ulcer Treatment Trial$218,704
R34 · FY2012 · EY · contact PI
Optimal trachoma control after mass antibiotic distributions$210,846
K23 · FY2012 · EY · contact PI
Optimal trachoma control after mass antibiotic distributions$206,712
K23 · FY2011 · EY · contact PI
Optimal trachoma control after mass antibiotic distributions$206,712
K23 · FY2010 · EY · contact PI
Optimal trachoma control after mass antibiotic distributions$178,912
K23 · FY2009 · EY · contact PI
Optimal trachoma control after mass antibiotic distributions$178,912
K23 · FY2008 · EY · contact PI